admin

Prof. Heather Wakelee Visits Second Xiangya Hospital for Academic Exchange

On June 15, Prof. Heather Wakelee from Stanford University visited the Second Xiangya Hospital of Central South University and met with Prof. Fang Wu’s team. They discussed lung cancer clinical research, covering high‑quality trial design, standardized management, and result translation. Prof. Wakelee, former IASLC President and current Director of Oncology at Stanford, provided constructive feedback […]

Prof. Heather Wakelee Visits Second Xiangya Hospital for Academic Exchange Read More »

Professor Fang Wu Participated in the 2026 “Thousand Doctors Grassroots Tour” in Linxiang, Hunan

On May 30, organized by the Youth League Committee of the Second Xiangya Hospital, Central South University, Professor Fang Wu and PhD student Yue Zeng attended the 2026 “Thousand Doctors Grassroots Tour” activity in Linxiang, Hunan Province. Professor Fang Wu patiently consulted dozens of cancer patients from Linxiang and surrounding areas at Linxiang People’s Hospital.

Professor Fang Wu Participated in the 2026 “Thousand Doctors Grassroots Tour” in Linxiang, Hunan Read More »

Professor Fang Wu Delivered a Speech at Asia-Pacific Thoracic Oncology Conference

On April 25, 2026, the Asia-Pacific Thoracic Oncology Conference was held in Hong Kong, China. The conference was organized by the Chinese University of Hong Kong and Hong Kong Society of Medical Oncology (HKSMO). Professor Tony Mok, Dr Herbert Loong, Dr Molly Li from The Chinese University of Hong Kong serving as the chair. The

Professor Fang Wu Delivered a Speech at Asia-Pacific Thoracic Oncology Conference Read More »

Seminar on Hunan Province Top 10 Decision-Consulting Projects & Launch of Central South University Clinical Research Zhang Xiao-qian Program

On the afternoon of April 28, the Seminar on the Top 10 Decision-Consulting Projects of the Hunan Provincial Association for Science and Technology and the Launch Meeting of the Central South University Clinical Research Zhang Xiao-qian Program were successfully held in Changsha. Supported by the decision-consulting project “Application of the Bio-Psycho-Social Medical Model in Cancer

Seminar on Hunan Province Top 10 Decision-Consulting Projects & Launch of Central South University Clinical Research Zhang Xiao-qian Program Read More »

2026 Wu Lab Undergraduate Winter Camp Concludes Successfully

In March 2026, the 2026 Wu Lab Undergraduate Winter Camp, hosted by the Wu Fang Research Group, drew to a successful close. Over a 28-day immersive program, nine outstanding undergraduate participants delved into the fascinating intersection of scientific research and clinical practice, embarking on a well-structured, professional and practical academic growth journey thoughtfully designed by

2026 Wu Lab Undergraduate Winter Camp Concludes Successfully Read More »

International MDT Meeting Thoracic Oncology MDT Team of The Second Xiangya Hospital Engages in Online Case Discussion with National Cancer Centre Singapore and Shanghai Chest Hospital

On March 12, 2026, an international online meeting of the “MDT Standardized Practice – Multidisciplinary Management Program for Lung Cancer” was successfully held. The meeting was chaired by Prof. Ziming Li from Shanghai Chest Hospital, Prof. Stephanie Saw Pei Li from the National Cancer Centre Singapore, and Prof. Fang Wu from The Second Xiangya Hospital

International MDT Meeting Thoracic Oncology MDT Team of The Second Xiangya Hospital Engages in Online Case Discussion with National Cancer Centre Singapore and Shanghai Chest Hospital Read More »

Dr. Fang Wu from the Second Xiangya Hospital Showcases Research at the American Association for Cancer Research (AACR) Annual Meeting 2025

From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting was held in Chicago. At this prestigious event, the research team led by Dr. Fang Wu from the Cancer Center of the Second Xiangya Hospital of Central South University, presented their study titled “Neoadjuvant EGFR-TKI therapy reshapes tumor immune microenvironment

Dr. Fang Wu from the Second Xiangya Hospital Showcases Research at the American Association for Cancer Research (AACR) Annual Meeting 2025 Read More »

Effects of novel coronavirus infection on immune function and status of patients with lung cancer

Research background and project basis Since the end of 2019, the coronavirus disease 2019 (COVID-19) has spread nationally and globally. COVID-19 is primarily caused by a β-coronavirus infection called SARS-CoV-2 and can affect systems throughout the body, but mostly the lungs. Patients with lung cancer experience more severe symptoms after infection with SARS-CoV-2, possibly because

Effects of novel coronavirus infection on immune function and status of patients with lung cancer Read More »

To explore the characteristics of tumor microenvironment in special immunotherapy population

Research background and project basis Since entering the era of immunotherapy, most cancer patients have been able to benefit from the treatment of immune checkpoint inhibitors, but due to study design limitations, Some special groups such as the elderly, patients with autoimmune diseases, tuberculosis (TB) disease infection, poor general condition or Acquired immune deficiency syndrome

To explore the characteristics of tumor microenvironment in special immunotherapy population Read More »

A multicenter, prospective clinical study to evaluate the efficacy and safety of stereotactic radiotherapy (SBRT) for patients with residual malignant pulmonary nodules after lung cancer surgery

Research background and project basis Lung cancer is the most deadly malignancy in the world. In recent years, with the implementation of CT screening for lung cancer, more and more pulmonary nodules, especially multiple pulmonary nodules, have been found, and a small number of multiple pulmonary nodules have been pathologically confirmed as multiple primary malignant

A multicenter, prospective clinical study to evaluate the efficacy and safety of stereotactic radiotherapy (SBRT) for patients with residual malignant pulmonary nodules after lung cancer surgery Read More »